{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T16:01:35Z","timestamp":1793289695120,"version":"4.5.0"},"reference-count":93,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2020-06250"],"award-info":[{"award-number":["2020-06250"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2022-01255"],"award-info":[{"award-number":["2022-01255"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018713","name":"Center for Innovative Medicine","doi-asserted-by":"publisher","award":["RS2020-0731"],"award-info":[{"award-number":["RS2020-0731"]}],"id":[{"id":"10.13039\/501100018713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018713","name":"Center for Innovative Medicine","doi-asserted-by":"publisher","award":["FoUI-962671"],"award-info":[{"award-number":["FoUI-962671"]}],"id":[{"id":"10.13039\/501100018713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018713","name":"Center for Innovative Medicine","doi-asserted-by":"publisher","award":["FoUI-973336"],"award-info":[{"award-number":["FoUI-973336"]}],"id":[{"id":"10.13039\/501100018713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["23 2665 Pj 01 H"],"award-info":[{"award-number":["23 2665 Pj 01 H"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jhepr.2025.101719","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:19:29Z","timestamp":1766535569000},"page":"101719","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Proteome-scale autoantibody profiling in PSC: Associations with clinical phenotypes and evidence for neuroendocrine deregulations"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7981-0927","authenticated-orcid":false,"given":"Martin","family":"Cornillet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiva Lundberg","family":"B\u00e5ve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghada","family":"Nouairia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Villard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aristeidis","family":"Grigoriadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"von Seth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannes","family":"Jansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Bueno","family":"\u00c1lvez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Bergstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Uhl\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Edfors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"St\u00e5l","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e5rten","family":"Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils","family":"Nyhlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Rorsman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Vessby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilsson","family":"Emma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Molinaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Bergquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stergios","family":"Kechagias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Antonella Burza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Lindstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Sparrelid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas K.","family":"Bj\u00f6rkstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Halfvarson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Bergquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jhepr.2025.101719_bib1","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","article-title":"Primary sclerosing cholangitis - a comprehensive review","volume":"67","author":"Karlsen","year":"2017","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101719_bib2","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/hep.32771","article-title":"AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma","volume":"77","author":"Bowlus","year":"2023","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jhepr.2025.101719_bib3","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1053\/j.gastro.2021.07.046","article-title":"Defining primary sclerosing cholangitis: results from an international primary sclerosing cholangitis study group consensus process","volume":"161","author":"Ponsioen","year":"2021","journal-title":"Gastroenterology"},{"issue":"10139","key":"10.1016\/j.jhepr.2025.101719_bib4","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1016\/S0140-6736(18)30300-3","article-title":"Primary sclerosing cholangitis","volume":"391","author":"Dyson","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jhepr.2025.101719_bib5","article-title":"EASL clinical practice guidelines on sclerosing cholangitis","volume":"77","author":"Liver","year":"2022","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.jhepr.2025.101719_bib6","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/cld.672","article-title":"Primary sclerosing cholangitis: unique aspects of disease in children","volume":"10","author":"Cotter","year":"2017","journal-title":"Clin Liver Dis (Hoboken)"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101719_bib7","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/hep.29204","article-title":"The natural history of primary sclerosing cholangitis in 781 children: a multicenter, international collaboration","volume":"66","author":"Deneau","year":"2017","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101719_bib8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/2050640617717156","article-title":"Impact of age at diagnosis on disease progression in patients with primary sclerosing cholangitis","volume":"6","author":"Rupp","year":"2018","journal-title":"United Eur Gastroenterol J"},{"issue":"1","key":"10.1016\/j.jhepr.2025.101719_bib9","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jhep.2023.09.031","article-title":"Inflammatory bowel disease and primary sclerosing cholangitis: one disease or two?","volume":"80","author":"van Munster","year":"2024","journal-title":"J Hepatol"},{"issue":"8","key":"10.1016\/j.jhepr.2025.101719_bib10","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1111\/tri.13925","article-title":"Recurrence of primary sclerosing cholangitis after liver transplantation - analysing the European Liver Transplant Registry and beyond","volume":"34","author":"Visseren","year":"2021","journal-title":"Transpl Int"},{"issue":"6","key":"10.1016\/j.jhepr.2025.101719_bib11","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/hep.26565","article-title":"Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis","volume":"58","author":"Boonstra","year":"2013","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.jhepr.2025.101719_bib12","article-title":"Development of a prognostic MRCP-score (DiStrict) for individuals with large-duct primary sclerosing cholangitis","volume":"4","author":"Grigoriadis","year":"2022","journal-title":"JHEP Rep"},{"issue":"23","key":"10.1016\/j.jhepr.2025.101719_bib13","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.3748\/wjg.v26.i23.3126","article-title":"Review of primary sclerosing cholangitis with increased IgG4 levels","volume":"26","author":"Manganis","year":"2020","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.jhepr.2025.101719_bib14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11894-018-0620-2","article-title":"The IBD and PSC phenotypes of PSC-IB(D)","volume":"20","author":"Ricciuto","year":"2018","journal-title":"Curr Gastroenterol Rep"},{"issue":"8","key":"10.1016\/j.jhepr.2025.101719_bib15","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1053\/j.gastro.2017.02.038","article-title":"Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis","volume":"152","author":"Weismuller","year":"2017","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.jhepr.2025.101719_bib16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cld.2015.08.005","article-title":"Primary sclerosing cholangitis: multiple phenotypes, multiple approaches","volume":"20","author":"Sarkar","year":"2016","journal-title":"Clin Liver Dis"},{"issue":"19","key":"10.1016\/j.jhepr.2025.101719_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10194476","article-title":"Systematic review of prognostic models compared to the Mayo risk score for primary sclerosing cholangitis","volume":"10","author":"Schmeltzer","year":"2021","journal-title":"J Clin Med"},{"issue":"5","key":"10.1016\/j.jhepr.2025.101719_bib18","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nrgastro.2016.154","article-title":"Genetics of primary sclerosing cholangitis and pathophysiological implications","volume":"14","author":"Jiang","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"24","key":"10.1016\/j.jhepr.2025.101719_bib19","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.3748\/wjg.14.3781","article-title":"Autoantibodies in primary sclerosing cholangitis","volume":"14","author":"Hov","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101719_bib20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1385\/CRIAI:28:2:115","article-title":"Role of auto-antibodies for the diagnosis of chronic cholestatic liver diseases","volume":"28","author":"Terjung","year":"2005","journal-title":"Clin Rev Allergy Immunol"},{"issue":"6","key":"10.1016\/j.jhepr.2025.101719_bib21","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0168-8278(05)80604-X","article-title":"A 2-year follow-up study of anti-neutrophil antibody in primary sclerosing cholangitis: relationship to clinical activity, liver biochemistry and ursodeoxycholic acid treatment","volume":"21","author":"Lo","year":"1994","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.jhepr.2025.101719_bib22","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1111\/j.1572-0241.2000.03292.x","article-title":"Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis","volume":"95","author":"Saarinen","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhepr.2025.101719_bib23","doi-asserted-by":"crossref","DOI":"10.1097\/HEP.0000000000000823","article-title":"Autoimmune diseases in primary sclerosing cholangitis and their first-degree relatives","author":"Lundberg","year":"2024","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.jhepr.2025.101719_bib24","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.dld.2011.05.009","article-title":"Immune-mediated diseases in primary sclerosing cholangitis","volume":"43","author":"Lamberts","year":"2011","journal-title":"Dig Liver Dis"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101719_bib25","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/cld.318","article-title":"Primary sclerosing cholangitis: one disease or several?","volume":"3","author":"Bowlus","year":"2014","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"10.1016\/j.jhepr.2025.101719_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108163","article-title":"Efficacy and safety of immune-modulating therapy for primary sclerosing cholangitis: a systematic review and meta-analysis","volume":"237","author":"Liu","year":"2022","journal-title":"Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101719_bib27","article-title":"Rituximab induction to prevent the recurrence of PSC after liver transplantation-the lessons learned from ABO-incompatible living donor liver transplantation","volume":"4","author":"Yamada","year":"2018","journal-title":"Transpl Direct"},{"issue":"5","key":"10.1016\/j.jhepr.2025.101719_bib28","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.jhep.2014.08.002","article-title":"Long-term outcome in PSC\/AIH \"overlap syndrome\": does immunosuppression also treat the PSC component?","volume":"61","author":"Zenouzi","year":"2014","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101719_bib29","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00007611-198502000-00014","article-title":"Dunn G(D) Primary sclerosing cholangitis","volume":"78","author":"Alberti-Flor","year":"1985","journal-title":"South Med J"},{"issue":"1","key":"10.1016\/j.jhepr.2025.101719_bib30","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13317-020-00129-x","article-title":"The search for the Holy Grail: autoantigenic targets in primary sclerosing cholangitis associated with disease phenotype and neoplasia","volume":"11","author":"Lopens","year":"2020","journal-title":"Auto Immun Highlights"},{"issue":"3","key":"10.1016\/j.jhepr.2025.101719_bib31","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s41573-020-00092-2","article-title":"B cell depletion therapies in autoimmune disease: advances and mechanistic insights","volume":"20","author":"Lee","year":"2021","journal-title":"Nat Rev Drug Discov"},{"issue":"9","key":"10.1016\/j.jhepr.2025.101719_bib32","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1038\/s41587-022-01637-z","article-title":"Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cells","volume":"41","author":"Oh","year":"2023","journal-title":"Nat Biotechnol"},{"issue":"76","key":"10.1016\/j.jhepr.2025.101719_bib33","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abo0777","article-title":"Antigen-specific depletion of CD4(+) T cells by CAR T cells reveals distinct roles of higher- and lower-affinity TCRs during autoimmunity","volume":"7","author":"Yi","year":"2022","journal-title":"Sci Immunol"},{"issue":"16","key":"10.1016\/j.jhepr.2025.101719_bib34","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"Arbuckle","year":"2003","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jhepr.2025.101719_bib35","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41584-019-0186-x","article-title":"Inclusion body myositis: clinical features and pathogenesis","volume":"15","author":"Greenberg","year":"2019","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"10.1016\/j.jhepr.2025.101719_bib36","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1136\/annrheumdis-2012-202868","article-title":"The fibrin-derived citrullinated peptide \u03b260-74Cit60,72,74 bears the major ACPA epitope recognised by the rheumatoid arthritis-specific anticitrullinated fibrinogen autoantibodies and anti-CCP2 antibodies","volume":"73","author":"Cornillet","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"5 Pt A","key":"10.1016\/j.jhepr.2025.101719_bib37","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.nbt.2015.09.002","article-title":"Exploration of high-density protein microarrays for antibody validation and autoimmunity profiling","volume":"33","author":"Sj\u00f6berg","year":"2016","journal-title":"N Biotechnol"},{"key":"10.1016\/j.jhepr.2025.101719_bib38","article-title":"Prospective surveillance for cholangiocarcinoma in unselected individuals with primary sclerosing cholangitis","author":"Villard","year":"2022","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.jhepr.2025.101719_bib39","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1681\/ASN.2020101395","article-title":"Serine protease HTRA1 as a novel target antigen in primary membranous nephropathy","volume":"32","author":"Al-Rabadi","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jhepr.2025.101719_bib40","article-title":"Identification of novel autoantigens as potential biomarkers in juvenile idiopathic arthritis associated uveitis","volume":"10","author":"Arve-Butler","year":"2022","journal-title":"Front Pediatr"},{"issue":"6220","key":"10.1016\/j.jhepr.2025.101719_bib41","doi-asserted-by":"crossref","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.jhepr.2025.101719_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102526","article-title":"The Swedish initiative for the study of Primary sclerosing cholangitis (SUPRIM)","volume":"70","author":"Cornillet","year":"2024","journal-title":"EClinicalMedicine"},{"issue":"10","key":"10.1016\/j.jhepr.2025.101719_bib43","first-page":"1635","article-title":"Practical statistics for medical research","volume":"10","author":"Altman","year":"1991","journal-title":"Chapman and Hall"},{"key":"10.1016\/j.jhepr.2025.101719_bib44","series-title":"Handbook of parametric and nonparametric statistical procedures","author":"Welsh","year":"2003"},{"issue":"12","key":"10.1016\/j.jhepr.2025.101719_bib45","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/nbt1210-1248","article-title":"Towards a knowledge-based human protein atlas","volume":"28","author":"Uhlen","year":"2010","journal-title":"Nat Biotechnol"},{"issue":"6","key":"10.1016\/j.jhepr.2025.101719_bib46","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/ng.2653","article-title":"The genotype-tissue expression (GTEx) project","volume":"45","year":"2013","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.jhepr.2025.101719_bib47","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: kyoto encyclopedia of genes and genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"10.1016\/j.jhepr.2025.101719_bib48","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nrrheum.2017.134","article-title":"Functional autoantibodies targeting G protein-coupled receptors in rheumatic diseases","volume":"13","author":"Cabral-Marques","year":"2017","journal-title":"Nat Rev Rheumatol"},{"issue":"D1","key":"10.1016\/j.jhepr.2025.101719_bib49","first-page":"D845","article-title":"The DisGeNET knowledge platform for disease genomics: 2019 update","volume":"48","author":"Pi\u00f1ero","year":"2020","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101719_bib50","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/ng.3745","article-title":"Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease","volume":"49","author":"Ji","year":"2017","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.jhepr.2025.101719_bib51","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/ng.2616","article-title":"Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis","volume":"45","author":"Liu","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhepr.2025.101719_bib52","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/978-1-0716-0389-5_21","article-title":"AAgAtlas 1.0: a database of human autoantigens extracted from biomedical literature","volume":"2131","author":"Wang","year":"2020","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jhepr.2025.101719_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.628275","article-title":"The roles of TRIMs in antiviral innate immune signaling","volume":"11","author":"Shen","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101719_bib54","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1128\/MCB.01213-08","article-title":"DNA-binding and -bending activities of SAP30L and SAP30 are mediated by a zinc-dependent module and monophosphoinositides","volume":"29","author":"Viiri","year":"2009","journal-title":"Mol Cell Biol"},{"issue":"1","key":"10.1016\/j.jhepr.2025.101719_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.0040013","article-title":"A SAP30 complex inhibits IFN-beta expression in Rift Valley fever virus infected cells","volume":"4","author":"Le May","year":"2008","journal-title":"Plos Pathog"},{"issue":"8","key":"10.1016\/j.jhepr.2025.101719_bib56","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/boc.201300087","article-title":"Cep126 is required for pericentriolar satellite localisation to the centrosome and for primary cilium formation","volume":"106","author":"Bonavita","year":"2014","journal-title":"Biol Cell"},{"issue":"8","key":"10.1016\/j.jhepr.2025.101719_bib57","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000496","article-title":"Epigenetic disease markers in primary sclerosing cholangitis and primary biliary cholangitis-methylomics of cholestatic liver disease","volume":"8","author":"Juran","year":"2024","journal-title":"Hepatol Commun"},{"issue":"10","key":"10.1016\/j.jhepr.2025.101719_bib58","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1016\/j.cell.2025.03.013","article-title":"Human proteome distribution atlas for tissue-specific plasma proteome dynamics","volume":"188","author":"Malmstr\u00f6m","year":"2025","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.jhepr.2025.101719_bib59","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S1474-4422(25)00194-2","article-title":"\u03b1-synuclein biomarker assays: bridging research and patient care","volume":"24","author":"Agin-Liebes","year":"2025","journal-title":"Lancet Neurol"},{"issue":"6","key":"10.1016\/j.jhepr.2025.101719_bib60","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/his.12813","article-title":"A global proteomic study identifies distinct pathological features of IgG4-related and primary sclerosing cholangitis","volume":"68","author":"Zen","year":"2016","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.jhepr.2025.101719_bib61","article-title":"Liver transcriptome analysis reveals PSC-attributed gene set associated with fibrosis progression","volume":"7","author":"Laschtowitz","year":"2025","journal-title":"JHEP Rep"},{"issue":"6","key":"10.1016\/j.jhepr.2025.101719_bib62","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1038\/s41591-023-02372-x","article-title":"Antigen-driven colonic inflammation is associated with development of dysplasia in primary sclerosing cholangitis","volume":"29","author":"Shaw","year":"2023","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101719_bib63","article-title":"Whole blood RNA sequencing identifies transcriptional differences between primary sclerosing cholangitis and ulcerative colitis","volume":"6","author":"Wacker","year":"2024","journal-title":"JHEP Rep"},{"issue":"5","key":"10.1016\/j.jhepr.2025.101719_bib64","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.jhep.2023.12.023","article-title":"Single-cell, single-nucleus, and spatial transcriptomics characterization of the immunological landscape in the healthy and PSC human liver","volume":"80","author":"Andrews","year":"2024","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.jhepr.2025.101719_bib65","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/gutjnl-2016-311739","article-title":"Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitis","volume":"66","author":"Jendrek","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2025.101719_bib66","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.3389\/fimmu.2018.01959","article-title":"Mucosal autoimmunity to cell-bound GP2 isoforms is a sensitive marker in PSC and associated with the clinical phenotype","volume":"9","author":"Sowa","year":"2018","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101719_bib67","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/apt.16153","article-title":"Anti-glycoprotein 2 (anti-GP2) IgA and anti-neutrophil cytoplasmic antibodies to serine proteinase 3 (PR3-ANCA): antibodies to predict severe disease, poor survival and cholangiocarcinoma in primary sclerosing cholangitis","volume":"53","author":"Wunsch","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.jhepr.2025.101719_bib68","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41598-017-18622-1","article-title":"Loss of tolerance to gut immunity protein, glycoprotein 2 (GP2) is associated with progressive disease course in primary sclerosing cholangitis","volume":"8","author":"Tornai","year":"2018","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jhepr.2025.101719_bib69","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41423-020-00568-6","article-title":"Antigen presentation, autoantibody production, and therapeutic targets in autoimmune liver disease","volume":"18","author":"Horst","year":"2021","journal-title":"Cell Mol Immunol"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101719_bib70","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s13317-013-0046-7","article-title":"Autoantibodies in liver disease: important clues for the diagnosis, disease activity and prognosis","volume":"4","author":"Himoto","year":"2013","journal-title":"Auto Immun Highlights"},{"key":"10.1016\/j.jhepr.2025.101719_bib71","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3389\/fimmu.2018.00541","article-title":"Autoantibodies associated with connective tissue diseases: what meaning for clinicians?","volume":"9","author":"Didier","year":"2018","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.jhepr.2025.101719_bib72","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1021\/acs.jproteome.2c00799","article-title":"Human autoantigen atlas: searching for the hallmarks of autoantigens","volume":"22","author":"Wang","year":"2023","journal-title":"J Proteome Res"},{"issue":"8","key":"10.1016\/j.jhepr.2025.101719_bib73","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/hep4.1200","article-title":"Gut and liver B cells of common clonal origin in primary sclerosing cholangitis-inflammatory bowel disease","volume":"2","author":"Chung","year":"2018","journal-title":"Hepatol Commun"},{"issue":"8","key":"10.1016\/j.jhepr.2025.101719_bib74","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41581-023-00720-1","article-title":"Pathogenesis of autoimmune disease","volume":"19","author":"Pisetsky","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.jhepr.2025.101719_bib75","article-title":"Genetic link between primary sclerosing cholangitis and thyroid dysfunction: a bidirectional two-sample Mendelian randomization study","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.jhepr.2025.101719_bib76","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13293-019-0265-3","article-title":"The influence of biological sex and sex hormones on bile acid synthesis and cholesterol homeostasis","volume":"10","author":"Phelps","year":"2019","journal-title":"Biol Sex Differ"},{"issue":"1","key":"10.1016\/j.jhepr.2025.101719_bib77","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1053\/j.gastro.2006.07.023","article-title":"Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver","volume":"132","author":"Alvaro","year":"2007","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.jhepr.2025.101719_bib78","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13040813","article-title":"Anti-cancer auto-antibodies: roles, applications and open issues","volume":"13","author":"de Jonge","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jhepr.2025.101719_bib79","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1190883","article-title":"Cancer\/testis antigens: promising immunotherapy targets for digestive tract cancers","volume":"14","author":"Ai","year":"2023","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.jhepr.2025.101719_bib80","doi-asserted-by":"crossref","DOI":"10.3390\/cells12060926","article-title":"Biology of cancer-testis antigens and their therapeutic implications in cancer","volume":"12","author":"Nin","year":"2023","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.jhepr.2025.101719_bib81","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat Rev Immunol"},{"issue":"7837","key":"10.1016\/j.jhepr.2025.101719_bib82","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41586-020-2700-3","article-title":"Sex differences in immune responses that underlie COVID-19 disease outcomes","volume":"588","author":"Takahashi","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jhepr.2025.101719_bib83","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jtbi.2014.11.022","article-title":"Unresolved issues in theories of autoimmune disease using myocarditis as a framework","volume":"375","author":"Root-Bernstein","year":"2015","journal-title":"J Theor Biol"},{"key":"10.1016\/j.jhepr.2025.101719_bib84","article-title":"Epstein barr virus and autoimmune responses in systemic lupus erythematosus","volume":"11","author":"Jog","year":"2020","journal-title":"Front Immunol"},{"issue":"7900","key":"10.1016\/j.jhepr.2025.101719_bib85","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41586-022-04432-7","article-title":"Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM","volume":"603","author":"Lanz","year":"2022","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.jhepr.2025.101719_bib86","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1038\/s41591-021-01409-3","article-title":"Population-wide diversity and stability of serum antibody epitope repertoires against human microbiota","volume":"27","author":"Vogl","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.jhepr.2025.101719_bib87","article-title":"Identifying a therapeutic window of opportunity for people living with primary sclerosing cholangitis: embryology and the overlap of inflammatory bowel disease with immune-mediated liver injury","author":"Kellermayer","year":"2024","journal-title":"Hepatology"},{"issue":"30","key":"10.1016\/j.jhepr.2025.101719_bib88","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abg5733","article-title":"Disorganization and degeneration of liver sympathetic innervations in nonalcoholic fatty liver disease revealed by 3D imaging","volume":"7","author":"Adori","year":"2021","journal-title":"Sci Adv"},{"issue":"9","key":"10.1016\/j.jhepr.2025.101719_bib89","first-page":"145","article-title":"Intrahepatic bile ducts guide establishment of the intrahepatic nerve network in developing and regenerating mouse liver","author":"Tanimizu","year":"2018","journal-title":"Development"},{"issue":"11","key":"10.1016\/j.jhepr.2025.101719_bib90","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/hepr.14125","article-title":"The role of the nervous system in liver diseases","volume":"54","author":"Mravec","year":"2024","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jhepr.2025.101719_bib91","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1241069","article-title":"Editorial: gut-liver-brain axis: a complex network influences human health and diseases","volume":"17","author":"Wu","year":"2023","journal-title":"Front Neurosci"},{"issue":"16","key":"10.1016\/j.jhepr.2025.101719_bib92","doi-asserted-by":"crossref","first-page":"5599","DOI":"10.1002\/cam4.4121","article-title":"Gamma-synuclein is a novel prognostic marker that promotes tumor cell migration in biliary tract carcinoma","volume":"10","author":"Takemura","year":"2021","journal-title":"Cancer Med"},{"issue":"1","key":"10.1016\/j.jhepr.2025.101719_bib93","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s40478-021-01136-3","article-title":"Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson's disease","volume":"9","author":"Reyes","year":"2021","journal-title":"Acta Neuropathol Commun"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555925004021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555925004021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T19:43:05Z","timestamp":1778096585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555925004021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":93,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2589555925004021"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2025.101719","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proteome-scale autoantibody profiling in PSC: Associations with clinical phenotypes and evidence for neuroendocrine deregulations","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2025.101719","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"101719"}}